AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23279217
Drug: TZP-102 (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TZP-102 (any dose)
Trial: 21639938
Drug: Educational interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational interventions consisting of a standardized teaching course aimed at doctors and nurses, lasting 6 hours split into three 2-hour blocks with subsequent monthly refresher courses.
Trial: 16856219
Drug: Flunitrazepam (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (1.0 mg; 1.3 mg)
Trial: 9377171
Drug: Recombinant interleukin‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant interleukin‐1 receptor antagonist (placebo-controlled)
Trial: 8383943
Drug: WIN 54954
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: WIN 54954 (600 mg per dose, two doses on the first day followed by three doses on each of the subsequent 5 days)
Trial: 3978010
Drug: Bupivacaine-fentanyl mixtures
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine-fentanyl mixtures (all doses)
Trial: 28990633
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training focused on ankle strengthening and mobility, twice per week for 10 weeks.
Trial: 22801062
Drug: Albumin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin (single intravenous dose at the time of LVP)
Trial: 22801062
Drug: Vasoconstrictor combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasoconstrictor combination of octreotide (20 mg intramuscular injection monthly) and midodrine (10 mg oral, 3 times/day)
Trial: 18761243
Drug: Remifentanil 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.5 microg/kg followed by 1 mg/kg of propofol
Trial: 18761243
Drug: Fentanyl 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.5 microg/kg followed by 1 mg/kg of propofol
Trial: 12063371
Drug: Intranasal mupirocin
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal mupirocin (among S. aureus carriers)
Trial: 10589634
Drug: Clonidine-morphine group
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine-morphine group (oral clonidine 5 microg/kg + epidural morphine 2 mg)
Trial: 10589634
Drug: Clonidine-morphine group
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine-morphine group
Trial: 10589634
Drug: Placebo-morphine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-morphine group
Trial: 8609105
Drug: Acute repair
RxNorm normalized name: hyaluronic acid Ophthalmic Gel [Optimend Corneal Repair]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute repair with a synthetic ligament-augmentation device (Group 2)
Trial: 6870163
Drug: Clonixin 300
RxNorm normalized name: clonixin
DrugBank: Clonixin (DB09218)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonixin 300 mg three times daily
Trial: 6870163
Drug: Oxyphenbutazone 100
RxNorm normalized name: oxyphenbutazone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxyphenbutazone 100 mg three times daily
Trial: 27354118
Drug: QAW039 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QAW039 (500 mg once daily)
Trial: 21779093
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume (LV) alginate preload (9.9 g alginate in 330 ml)
Trial: 21779093
Drug: High volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High volume (HV) alginate preload (15.0 g alginate in 500 ml)
Trial: 12211496
Drug: Regular dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular dose aspirin (325 mg)
Trial: 8949670
Drug: Iodixanol 320
RxNorm normalized name: IODIXANOL 320mgI/ml INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol 320 mgI ml‐1 (Visipaque)
Trial: 8949670
Drug: Iohexol 350
RxNorm normalized name: iohexol 350 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iohexol 350 mgI ml‐1 (Omnipaque)
Trial: 8949670
Drug: Iodixanol (60-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodixanol (60-100 ml)
Trial: 8949670
Drug: Iohexol (60-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iohexol (60-100 ml)
Trial: 26009712
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg tablets thrice daily for 7 days
Trial: 26009712
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (cetirizine 10 mg OD and calamine)
Trial: 21999640
Drug: Technosphere inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technosphere inhaled insulin + insulin glargine (TI+G)
Trial: 21999640
Drug: Premixed aspart
RxNorm normalized name: aspartate
DrugBank: Potassium aspartate (DB15819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premixed aspart insulin 70/30
Trial: 19735497
Drug: NIDCAP (treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIDCAP (treatment, E)
Trial: 12606844
Drug: Flupenthixol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupenthixol (mean daily dose 6.6 mg/day)
Trial: 12606844
Drug: Risperidone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (mean daily dose 3.6 mg/day)
Trial: 10173126
Drug: Micronised fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised fenofibrate 200 mg
Trial: 10173126
Drug: Micronised fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised fenofibrate 200 mg (type IIa)
Trial: 10173126
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg (type IIa)
Trial: 10173126
Drug: Micronised fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised fenofibrate 200 mg (type IIb)
Trial: 10173126
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg (type IIb)
Trial: 8453546
Drug: Phosphorus-32 as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphorus-32 as primary adjuvant treatment
Trial: 8453546
Drug: Phosphorus-32 as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphorus-32 as consolidating therapy after second-look surgery
Trial: 8453546
Drug: Phosphorus-32 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphorus-32 treatment
Trial: 2937598
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 to 160 mg twice a day)
Trial: 2937598
Drug: Nitrendipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (5 to 20 mg twice a day)
Trial: 24516038
Drug: octreotide LAR
RxNorm normalized name: octreotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: octreotide LAR 30 mg intramuscularly every 4 weeks
Trial: 24516038
Drug: Physician's treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physician's treatment of choice in case of diarrhea
Trial: 18827176
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/day (titrated to 10 mg if BP goal not achieved)
Trial: 11392163
Drug: OAT-omeprazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAT-omeprazole (2 x 20 mg), amoxycillin (2 x 1000 mg), tinidazole (2 x 500 mg)
Trial: 11392163
Drug: OAC-omeprazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAC-omeprazole (2 x 20 mg), amoxycillin (2 x 1000 mg), clarithromycin (2 x 250 mg)
Trial: 8842111
Drug: Arteflene (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arteflene (25 mg/kg)
Trial: 1503438
Drug: S-1108 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1108 (200 mg TID for 8 days)
Trial: 26884585
Drug: Apatinib 850
RxNorm normalized name: Apatinib
DrugBank: Rivoceranib (DB14765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib 850 mg once daily
Trial: 15989829
Drug: Relaxation techniques
RxNorm normalized name: Relax-DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation techniques (RT) combined with conventional treatment
Trial: 12466335
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg androstenedione
Trial: 12466335
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg androstenedione)
Trial: 10466913
Drug: Rhesus‐human reassortant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhesus‐human reassortant rotavirus tetravalent vaccine (RRV‐TV)
Trial: 8554942
Drug: Alcohol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.8 g kg‐1)
Trial: 8554942
Drug: Alcohol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.8 g kg‐1) + Caffeine (400 mg)
Trial: 1939687
Drug: Trimeprazine tartrate
RxNorm normalized name: Trimeprazine Tartrate
DrugBank: Alimemazine (DB01246)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trimeprazine tartrate (sedative medication) prescribed in a reducing dose over the first 10 days of extinction
Trial: 1939687
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered double-blind
Trial: 28648803
Drug: Sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (400 mg twice-daily)
Trial: 11460023
Drug: Nonoxynol-9 gel
RxNorm normalized name: Nonoxynol 9
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoxynol-9 gel (52.5 mg)
Trial: 10423625
Drug: edrophonium (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edrophonium (1 mg/kg) and atropine (0.01 mg/kg) reversal (E/A)
Trial: 3860788
Drug: Prostaglandin F2
RxNorm normalized name: Prostaglandin F2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin F2 alpha (16 mg diluted in 40 mL of saline)
Trial: 29469430
Drug: Conventional nursing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional nursing plus solution focused approach
Trial: 18514729
Drug: Prednisolone (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (35 mg once a day)
Trial: 10417579
Drug: Topical onion
RxNorm normalized name: ONION
DrugBank: Onion (DB10548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical onion gel extract
Trial: 10417579
Drug: Topical emollient
RxNorm normalized name: HPR Topical Emollient Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical emollient ointment (petrolatum based)
Trial: 1904681
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone agonist (2 months before hysterectomy)
Trial: 1904681
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no agonist)
Trial: 31455700
Drug: Proactive case
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive case detection by CHWs with daily home visits and doorstep services
Trial: 15019156
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg/day for one year)
Trial: 9669136
Drug: 2% Minoxidil
RxNorm normalized name: MINOXIDIL 2 g in 100 mL TOPICAL LIQUID [2% Minoxidil hair growth serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% Minoxidil therapy
Trial: 7520956
Drug: Intraperitoneal 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal 5-fluorouracil and intravenous folinic acid Days 1-6 after operation
Trial: 4212040
Drug: Gentamicin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin plus daily granulocyte transfusion
Trial: 28001306
Drug: Doxapram (plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram (plasma concentration 1,000‐3,500 ng/mL)
Trial: 28001306
Drug: Alfentanil (plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (plasma concentration 100‐200 ng/mL)
Trial: 24253812
Drug: Low SMUG1
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low SMUG1 protein expression in ER+ cohort receiving adjuvant endocrine therapy
Trial: 24253812
Drug: Low SMUG1
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low SMUG1 protein expression in ER- cohort receiving adjuvant chemotherapy
Trial: 21704237
Drug: Extended-release tramadol/acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release tramadol/acetaminophen (tramadol 75 mg/acetaminophen 650 mg)
Trial: 21704237
Drug: Immediate-release tramadol/acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release tramadol/acetaminophen (tramadol 37.5 mg/acetaminophen 325 mg)
Trial: 16384765
Drug: Bexarotene gel
RxNorm normalized name: Bexarotene
DrugBank: Bexarotene (DB00307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bexarotene gel 1% with narrowband UVB phototherapy
Trial: 16384765
Drug: Vehicle gel
RxNorm normalized name: vehicle gel base no.61
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle gel with narrowband UVB phototherapy
Trial: 12771113
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin (0.625 mg conjugated equine estrogen with 2.5 mg medroxyprogesterone acetate)
Trial: 10852275
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg i.v. pulse of methylprednisolone followed by 0.7 mg/kg/day oral prednisone (Group 1)
Trial: 10852275
Drug: 0.7 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 mg/kg/day prednisone without an i.v. pulse (Group 2, controls)
Trial: 10852275
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg i.v. pulse of methylprednisolone followed by 0.5 mg/kg/day prednisone (Group 3)
Trial: 9089425
Drug: SDZ HTF
RxNorm normalized name: SDZ MSL 109
DrugBank: Sevirumab (DB17771)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDZ HTF 919 (HTF) 25 mg
Trial: 9089425
Drug: SDZ HTF
RxNorm normalized name: SDZ MSL 109
DrugBank: Sevirumab (DB17771)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDZ HTF 919 (HTF) 50 mg
Trial: 9089425
Drug: SDZ HTF
RxNorm normalized name: SDZ MSL 109
DrugBank: Sevirumab (DB17771)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SDZ HTF 919 (HTF) 100 mg
Trial: 3643648
Drug: Oral course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral course of pivampicillin/pivmecillinam (PAPM)
Trial: 3643648
Drug: Parenteral cefotaxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral cefotaxime (CFT)
Trial: 24169120
Drug: DermaVir (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DermaVir (0.1 or 0.4 mg of plasmid DNA at weeks 1, 7, and 13; 0.8 mg at weeks 0, 1, 6, 7, 12, and 13)
Trial: 24169120
Drug: DermaVir (intermediate-dose)
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DermaVir (intermediate-dose)
Trial: 22023876
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone tablets
Trial: 19916848
Drug: Quetiapine (58.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (58.3 mg/day)
Trial: 17030114
Drug: High calcium
RxNorm normalized name: Nutritional Supplement Oral Liquid [ENSURE HIGH CALCIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calcium skim milk without added phylloquinone (1000 mg/d of extra calcium)
Trial: 9408414
Drug: Minilaparotomy (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minilaparotomy (ML)
Trial: 9408414
Drug: Minilaparotomy (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minilaparotomy (ML) and Conventional Approach (CA)
Trial: 8431122
Drug: Desmopressin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin plus warfarin therapy
Trial: 9773802
Drug: Oral ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ondansetron (24 mg) plus dexamethasone (12 mg)
Trial: 9773802
Drug: i.v. ondansetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ondansetron (8 mg) plus dexamethasone (20 mg)
Trial: 7824325
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg intravenous dose of vancomycin over 90 min upon anesthesia (Group 1)
Trial: 7824325
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg intravenous dose of vancomycin followed by a second 7.5 mg/kg intravenous dose over 30 min (Group 2)
Trial: 27682331
Drug: PSALTI intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PSALTI intervention (physiotherapy and speech and language therapy) consisting of education, laryngeal hygiene and hydration, cough suppression techniques, breathing exercises and psychoeducational counselling.
Trial: 27682331
Drug: PSALTI intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PSALTI intervention (physiotherapy and speech and language therapy).
Trial: 24069469
Drug: Single-dose albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose albendazole (400 mg) treatment followed by health hygiene education intervention.
Trial: 16443788
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion during adenosine-induced hyperemia
Trial: 14735177
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel plus cisplatin (PC) - Paclitaxel 66 mg/m² i.v. on days 1, 8, and 15; Cisplatin 60 mg/m² i.v. on day 15.
Trial: 14735177
Drug: Vinorelbine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine plus cisplatin (VC) - Vinorelbine 23 mg/m² i.v. on days 1, 8, and 15; Cisplatin 60 mg/m² i.v. on day 15.
Trial: 9441769
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral intake (clear liquid diet on postoperative day 1, regular diet after tolerating 500 cc)
Trial: 9441769
Drug: Traditional dietary
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dietary advancement (oral intake initiated after bowel function is documented)
Trial: 3281603
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CyA) at an initial dosage of 5 mg/kg daily
Trial: 23608654
Drug: Riboflavin (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin (1.6 mg/d) for 16 weeks
Trial: 21691817
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Vitamin D2 supplementation (HDD) 50,000 IU capsules weekly for 8 weeks then monthly for 4 months (Stratum A)
Trial: 21691817
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Vitamin D2 supplementation (HDD) for 16 weeks and then monthly for 2 months (Stratum B)
Trial: 21691817
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Vitamin D2 supplementation (HDD)
Trial: 22813231
Drug: Stimulation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulation therapy
Trial: 2570582
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Ridazolol and Molsidomine
Trial: 29325336
Drug: Ropivacaine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (all doses)
Trial: 25307476
Drug: skintrek cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: skintrek cream PUVA
Trial: 16816861
Drug: PEG-INF alpha-2a
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG-INF alpha-2a (180 microg or 135 microg/week) and RBV 900 mg/d
Trial: 16816861
Drug: IFNalpha-2a (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNalpha-2a (5 MIU/qod) and RBV 900 mg/d
Trial: 11145354
Drug: Single-bottle bonding
RxNorm normalized name: bottlebrush pollen extract
DrugBank: Callistemon citrinus pollen (DB10943)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-bottle bonding agents
Trial: 8885118
Drug: 4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg/kg gentamicin loading dose
Trial: 8885118
Drug: 2.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/kg gentamicin standard dose
Trial: 8885118
Drug: Two SGC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two SGC after the first dose
Trial: 29967332
Drug: 0.5 ug/kg dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ug/kg dexmedetomidine + 100 μg sufentanil + 300 μg dexmedetomidine (study group)
Trial: 29967332
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline + 100 μg sufentanil (control group)
Trial: 24113055
Drug: 3-Dimensional Conformal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
Trial: 7948436
Drug: High-dose surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose surfactant treatment (200 mg/kg)